Gogas, Helen J <br/><br/>
Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  09 2019 
 - 97-106 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2019.07.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Carbamates--administration & dosage<br/>Fatigue--chemically induced<br/>Female<br/>Humans<br/>Incidence<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Mutation<br/>Nausea--chemically induced<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Skin Neoplasms--drug therapy<br/>Sulfonamides--administration & dosage<br/>Vemurafenib--administration & dosage<br/>Vomiting--chemically induced